Affiliation:
1. Saint Luke’s Health System, Kansas City, Missouri.
Abstract
The Global Initiative for Chronic Obstructive Lung Disease Report provides guidance on prevention and management of chronic obstructive pulmonary disease (COPD), a pulmonary syndrome largely impacting older adults. Management of COPD in this patient population is often further complicated
because of medication and disease state interactions. Pharmacists are in a unique position to impact patients with COPD through counseling on proper medication selection, disease state education, adherence, and proper inhaler technique.
Publisher
American Society of Consultant Pharmacists
Reference22 articles.
1. The Global Health Observatory, Global Health Estimates: Life expectancy and leading causes of death and disability.,2022
2. Update on clinical aspects of chronic obstructive pulmonary disease.;N Engl J Med.,2019
3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2023 report.
4. Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomized trial.;Respir Res.,2019